Cellectis S.A.
CLLS
$3.24
-$0.08-2.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.23M | 5.78M | 10.40M | 35.17M | 16.73M |
| Total Other Revenue | 1.68M | 1.77M | 1.81M | 1.99M | 1.47M |
| Total Revenue | 6.90M | 7.55M | 12.21M | 37.16M | 18.19M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.90M | 7.55M | 12.21M | 37.16M | 18.19M |
| SG&A Expenses | 5.74M | 5.59M | 4.80M | 5.21M | 5.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -290.00K | -63.00K | 320.00K | -154.00K | -378.00K |
| Total Operating Expenses | 30.43M | 32.72M | 29.56M | 29.12M | 27.78M |
| Operating Income | -23.52M | -25.17M | -17.35M | 8.04M | -9.59M |
| Income Before Tax | -21.79M | -17.72M | -26.74M | 589.00K | -23.74M |
| Income Tax Expenses | 25.00K | 46.00K | -423.00K | -- | -- |
| Earnings from Continuing Operations | -21.82M | -17.77M | -26.32M | 589.00K | -23.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.82M | -17.77M | -26.32M | 589.00K | -23.74M |
| EBIT | -23.52M | -25.17M | -17.35M | 8.04M | -9.59M |
| EBITDA | -20.39M | -22.13M | -15.33M | 11.17M | -6.46M |
| EPS Basic | -0.22 | -0.18 | -0.26 | 0.01 | -0.24 |
| Normalized Basic EPS | -0.14 | -0.11 | -0.17 | 0.00 | -0.15 |
| EPS Diluted | -0.22 | -0.18 | -0.26 | 0.01 | -0.24 |
| Normalized Diluted EPS | -0.14 | -0.11 | -0.17 | 0.00 | -0.15 |
| Average Basic Shares Outstanding | 100.65M | 100.53M | 100.33M | 100.33M | 100.31M |
| Average Diluted Shares Outstanding | 100.65M | 100.53M | 100.33M | 101.71M | 100.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |